96 related articles for article (PubMed ID: 8085739)
1. Preoperative imaging of parathyroid carcinoma by positron emission tomography.
Neumann DR; Esselstyn CB; Siciliano D; MacIntyre WJ; Kohse LM; Licata AA
Ann Otol Rhinol Laryngol; 1994 Sep; 103(9):741-5. PubMed ID: 8085739
[No Abstract] [Full Text] [Related]
2. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Neumann DR; Esselstyn CB; Kim EY
J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
[TBL] [Abstract][Full Text] [Related]
3. Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography.
Arslan N; Rydzewski B
Clin Nucl Med; 2002 Mar; 27(3):221-2. PubMed ID: 11852320
[No Abstract] [Full Text] [Related]
4. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism.
Melon P; Luxen A; Hamoir E; Meurisse M
Eur J Nucl Med; 1995 Jun; 22(6):556-8. PubMed ID: 7556303
[TBL] [Abstract][Full Text] [Related]
5. Nonfunctioning parathyroid carcinoma.
Klink BK; Karulf RE; Maimon WN; Peoples JB
Am Surg; 1991 Jul; 57(7):463-7. PubMed ID: 1647716
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid adenoma localization by PET FDG.
Neumann DR; Esselstyn CB; MacIntyre WJ; Chen EQ; Go RT; Kohse LM
J Comput Assist Tomogr; 1993; 17(6):976-7. PubMed ID: 8227589
[TBL] [Abstract][Full Text] [Related]
7. Thallium-201 uptake in lung cancer.
Chin BB; Zukerberg BW; Buchpiguel C; Alavi A
J Nucl Med; 1995 Aug; 36(8):1514-9. PubMed ID: 7629600
[No Abstract] [Full Text] [Related]
8. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Scott GC; Meier DA; Dickinson CZ
J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic imaging using 201Tl and 99mTc-pertechnetate in hyperparathyroidism].
Gimlette TM; Brownless SM
Med Radiol (Mosk); 1989 May; 34(5):32-44. PubMed ID: 2542714
[No Abstract] [Full Text] [Related]
10. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
Giordano A; Galli J; Corina L; Samanes Gajate AM; D'Andrea G; Almadori G
Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
[TBL] [Abstract][Full Text] [Related]
11. Unilateral parathyroidectomy: the role of thallium-technetium subtraction scans.
Davis RK; Hoffmann J; Dart D; Datz FL
Otolaryngol Head Neck Surg; 1990 Jun; 102(6):635-8. PubMed ID: 2165235
[TBL] [Abstract][Full Text] [Related]
12. Functional imaging using PET and SPECT in pediatric neurology.
Messa C; Grana C; Lucignani G; Fazio F
J Nucl Biol Med (1991); 1994 Mar; 38(1):85-8. PubMed ID: 8075181
[No Abstract] [Full Text] [Related]
13. [Subtraction scintigraphy using Tc99m/Tl 201 in the preoperative localization of adenomas of the parathyroid].
Noguera EC; Mothe G; Siman GI; Wyse EP
Medicina (B Aires); 1985; 45(6):698-9. PubMed ID: 3023792
[No Abstract] [Full Text] [Related]
14. [Diagnosis of adenoma and parathyroid hyperplasia using subtraction scintigraphy with thallium 201-Tc99m].
González P; Pumarino H; Gac A; Saffie A; Olea E; Sirandoni G; Campino C; Garcés N
Rev Med Chil; 1988 Jul; 116(7):633-9. PubMed ID: 2855755
[No Abstract] [Full Text] [Related]
15. Parathyroid carcinoma. Report of three cases.
Stavraka-Kakavaki A; Fronistas O; Toumbouros M; Manolas C
Clin Nucl Med; 1992 Jan; 17(1):1-3. PubMed ID: 1311997
[TBL] [Abstract][Full Text] [Related]
16. The use of preoperative localization of adenomas of the parathyroid glands by thallium-technetium subtraction scintigraphy, high-resolution ultrasonography and computed tomography.
Roses DF; Sudarsky LA; Sanger J; Raghavendra BN; Reede DL; Blum M
Surg Gynecol Obstet; 1989 Feb; 168(2):99-106. PubMed ID: 2536199
[TBL] [Abstract][Full Text] [Related]
17. Nuclear medicine imaging of breast cancer.
Van Eijck CH; Krenning EP; Kvols LK
Nucl Med Commun; 1996 Nov; 17(11):925-7. PubMed ID: 8971862
[No Abstract] [Full Text] [Related]
18. Tissue characterization in nuclear oncology: its time has come.
Lamki LM
J Nucl Med; 1995 Feb; 36(2):207-10. PubMed ID: 7830115
[No Abstract] [Full Text] [Related]
19. Methodological considerations influence the clinical value of parathyroid localisation diagnostics.
Gabriel M; Erler H; Bacher-Stier C; Kendler D; Donnemiller E; Decristoforo C; Moncayo R
Eur J Nucl Med; 2001 Jul; 28(7):942-3. PubMed ID: 11504097
[No Abstract] [Full Text] [Related]
20. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.
Neumann DR; Esselstyn CB; Maclntyre WJ; Go RT; Obuchowski NA; Chen EQ; Licata AA
J Nucl Med; 1996 Nov; 37(11):1809-15. PubMed ID: 8917180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
